Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Tumor”

5,088 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,088 results

Not applicableEnded earlyNCT06164691
What this trial is testing

Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsRectal Neoplasms
Matthew Neal MD 2
Large-scale testing (Phase 3)Study completedNCT00679913
What this trial is testing

Standardization of Surgery on the Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 244
Testing effectiveness (Phase 2)UnknownNCT02133079
What this trial is testing

Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

Who this might be right for
Liver CancerPancreatic Adenocarcinoma
Cure&Sure Biotech Co., LTD 20
Not applicableStudy completedNCT01664169
What this trial is testing

Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 307
Not applicableStudy completedNCT01138124
What this trial is testing

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Who this might be right for
Renal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more
GlaxoSmithKline 54,202
Testing effectiveness (Phase 2)UnknownNCT05371223
What this trial is testing

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases

Who this might be right for
Peritoneal CarcinomatosisPancreas Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Testing effectiveness (Phase 2)Study completedNCT00390182
What this trial is testing

Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)

Who this might be right for
Gastrointestinal NeoplasmsOvarian Neoplasms
University of Maryland, Baltimore 38
Large-scale testing (Phase 3)WithdrawnNCT03536182
What this trial is testing

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
University of Texas Southwestern Medical Center
Post-approval studies (Phase 4)Study completedNCT02261896
What this trial is testing

Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions

Who this might be right for
Pancreatic Cystic Lesion
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 226
Not applicableUnknownNCT05831488
What this trial is testing

Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer

Who this might be right for
Hepato-Biliary Carcinoma in Situ NosPancreatic CancerColorectal Cancer+2 more
Royal Marsden NHS Foundation Trust 35
Testing effectiveness (Phase 2)Study completedNCT00267020
What this trial is testing

Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasm
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT00089024
What this trial is testing

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Nebraska 29
Testing effectiveness (Phase 2)Looking for participantsNCT06587061
What this trial is testing

HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02315625
What this trial is testing

Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more
National Cancer Institute (NCI) 16
Not applicableLooking for participantsNCT04743479
What this trial is testing

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

Who this might be right for
Pancreatic CancerDiabetesFamilial Pancreatic Cancer+3 more
Changhai Hospital 5,000
Early research (Phase 1)Active Not RecruitingNCT07457541
What this trial is testing

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Pancreas Cancer, MetastaticBreast Cancer (Locally Advanced or Metastatic)+1 more
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Not applicableUnknownNCT05802420
What this trial is testing

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdvanced CancerMetastatic Cancer
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00602082
What this trial is testing

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 84
Testing effectiveness (Phase 2)Looking for participantsNCT06345079
What this trial is testing

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumors
Australasian Gastro-Intestinal Trials Group 78
Next Page